Mazdutide 10 mg

Dragon Pharma Mazdutide

Mazdutide 10 mg represents the cutting edge of metabolic peptide therapy—a sophisticated dual GLP-1 and glucagon receptor agonist that delivers unparalleled fat loss and metabolic optimization through simultaneous appetite suppression and energy expenditure enhancement. This third-party verified product contains 9.11 mg of ultra-pure Mazdutide per vial, demonstrating Dragon Pharma's commitment to precise formulation and quality assurance. Each vial delivers pharmaceutical-grade peptide in lyophilized form, manufactured in EU-certified facilities under conditions that preserve the complex molecular structure required for dual receptor activation and sustained metabolic effects.

Mazdutide operates through a revolutionary dual-mechanism approach that addresses weight management from both intake and expenditure perspectives. As a GLP-1 receptor agonist, it enhances glucose-dependent insulin secretion, slows gastric emptying, promotes satiety, and reduces food intake through central nervous system appetite regulation. Simultaneously, its glucagon receptor activation increases energy expenditure, enhances hepatic glucose production, promotes lipolysis, and stimulates thermogenesis—creating a powerful synergy that accelerates fat loss beyond what either mechanism could achieve alone. For bodybuilders and athletes, this dual action makes Mazdutide particularly valuable during cutting phases: while traditional appetite suppressants merely reduce caloric intake, Mazdutide also actively increases calorie burning, making it exceptionally effective for breaking through fat loss plateaus and targeting stubborn adipose tissue.

The scientific innovation of Mazdutide lies in its balanced receptor activation profile. Unlike earlier incretin-based therapies that focused solely on GLP-1 pathways, Mazdutide's glucagon component activates hepatic cAMP production, increasing energy expenditure by up to 15-20% while maintaining glucose homeostasis through coordinated insulin/glucagon signaling. This metabolic enhancement occurs without the catabolic risks of traditional stimulant fat burners like Clenbuterol or thyroid compounds like T3, making Mazdutide uniquely positioned to preserve lean muscle mass during aggressive calorie restriction. The extended half-life (approximately 120 hours) allows for once-weekly administration, providing consistent receptor occupancy without the peaks and troughs associated with daily compounds, while the subcutaneous route offers 100% bioavailability compared to the poor absorption of oral GLP-1 analogs.

Dragon Pharma's formulation utilizes pharmaceutical-grade Mazdutide with precise receptor affinity ratios optimized for metabolic enhancement rather than just glycemic control. The lyophilized powder ensures maximum stability, easily reconstituted with bacteriostatic water for subcutaneous administration. For athletes engaged in body recomposition protocols, Mazdutide provides comprehensive metabolic advantages: dramatic appetite suppression that makes calorie deficits manageable, enhanced fat oxidation during both exercise and rest periods, improved insulin sensitivity that directs nutrients toward muscle rather than fat storage, and metabolic rate elevation that persists throughout the dosing interval. When stacked with androgenic compounds like Testabol 400 or Masteron 200, Mazdutide creates a powerful synergy—the androgens preserve lean tissue and enhance nutrient partitioning while Mazdutide aggressively reduces adipose stores to reveal underlying muscularity.

Key Benefits:

• Dual-Mechanism Fat Loss: Combines GLP-1-mediated appetite suppression with glucagon-driven energy expenditure enhancement, producing superior weight loss results compared to single-pathway compounds through simultaneous reduction of caloric intake and increase of caloric burn.
• Metabolic Rate Enhancement: Increases resting energy expenditure by 15-20% through glucagon receptor activation of hepatic glucose production and thermogenesis, creating a sustained metabolic advantage that persists between meals and during sleep.
• Appetite Regulation & Satiety: Reduces hunger signals, delays gastric emptying, increases feelings of fullness, and decreases food cravings through central GLP-1 receptor activation in appetite control centers of the hypothalamus and brainstem.
• Insulin Sensitivity Improvement: Enhances glucose-dependent insulin secretion, reduces insulin resistance, improves glycemic control, and optimizes nutrient partitioning to direct calories toward muscle preservation rather than fat storage during cutting phases.
• Cardiometabolic Health Support: Improves lipid profiles, reduces visceral adipose tissue (particularly dangerous abdominal fat), supports healthy blood pressure, and provides endothelial benefits through multiple metabolic pathways.

Each 2 mL vial contains 10 mg of pharmaceutical-grade Mazdutide (actual 9.11 mg per independent lab analysis), manufactured under strict quality control standards in Dragon Pharma's certified European facilities.

Product Specifications

Usage Guidelines

Mazdutide is administered via subcutaneous injection once weekly. Reconstitute the 10 mg vial with 1-2 mL of bacteriostatic water. For optimal results, inject into abdominal subcutaneous fat, rotating injection sites weekly. The extended half-life allows for flexible dosing timing, though consistency (same day each week) helps maintain stable blood levels. Begin with lower doses and titrate upward every 4 weeks based on tolerance and response. Take with plenty of water and spread protein intake throughout the day to manage potential gastrointestinal side effects during the adaptation period. Combine with resistance training and adequate protein intake (1-1.2g per pound of target body weight) to maximize fat loss while preserving lean muscle mass.

• Beginner Cycle (12 weeks): 2 mg weekly for 4 weeks, then 3 mg weekly for 8 weeks for gradual adaptation and moderate fat loss. Ideal when using compounds like Anavar 10 or during moderate calorie deficits. Can be stacked with L-Carnitine 500 for enhanced fat oxidation synergy.
• Intermediate Cycle (16 weeks): 3 mg weekly for 4 weeks, then 5 mg weekly for 12 weeks for significant fat loss and metabolic enhancement. Effective alongside cutting compounds like Winstrol 50 or Primobolan 200 for enhanced definition and vascularity.
• Advanced Cycle (24 weeks): 5 mg weekly for 4 weeks, then 7-10 mg weekly for 20 weeks for maximum fat loss and competition preparation. Often stacked with Trenbolone 100 for extreme conditioning or Testo Blend 350 for mass-preserving extended cuts.

Fat Loss Optimization Protocol:

For stubborn abdominal fat: Inject into abdominal subcutaneous tissue and combine with fasting protocols—Mazdutide's appetite suppression makes extended fasting manageable. For metabolic reset: Use for 16-24 weeks to establish new body weight set point before transitioning to maintenance. When stacking with thyroid compounds like CY3, Mazdutide provides appetite control while thyroid enhances metabolic rate for synergistic effects. For athletes using Dragontropin, Mazdutide complements the fat loss effects while growth hormone preserves lean tissue.

Muscle Preservation Protocol:

During aggressive cuts: Maintain protein intake at 1-1.2g per pound of target body weight, time carbohydrates around workouts, and continue heavy resistance training. When using alongside androgens like Proviron or Masteron 100, the androgens protect muscle while Mazdutide aggressively reduces fat. For nutrient partitioning: Time Mazdutide administration to coincide with higher carbohydrate days if using cyclical dieting approaches. Monitor strength and performance—adjust calories upward if significant strength loss occurs.

Third-Party Lab Tested

2024-09-13

View Result

9.11 mg

Storage Instructions

• Unreconstituted: Store lyophilized Mazdutide vials at 2-8°C (36-46°F) in their original packaging. The peptide maintains stability for 24 months under consistent refrigeration. Avoid freezing as ice crystal formation can damage the complex peptide structure. Protect from light exposure which can degrade the molecule over time. Temperature fluctuations should be minimized to preserve peptide integrity.
• Reconstituted: After mixing with bacteriostatic water, store immediately in refrigerator at 2-8°C (36-46°F). Use within 28 days for maximum potency. The solution remains stable at room temperature for up to 24 hours if needed for travel. Never freeze reconstituted peptide as this causes irreversible aggregation and loss of biological activity. Discard if solution becomes cloudy or discolored.
• Handling Protocol: Use alcohol swabs on vial tops before each puncture. Gently swirl to dissolve powder completely—avoid vigorous shaking. For accurate dosing, use insulin syringes with 0.5mL or 1mL capacity. Rotate abdominal injection sites weekly to prevent lipohypertrophy. Document administration dates and doses for consistent weekly scheduling.